Xometry, Inc. (XMTR) Balance Sheet

The dramatic increase in equity from $282.0M to $595.0M in 2026Q2, alongside a stable debt level, suggests a significant equity issuance, likely a convertible note conversion or new equity raise. This bolsters the balance sheet but also signals that the company is relying on external funding to support its growth, as retained losses continue to accumulate. The trajectory appears to be one of deliberate balance sheet expansion to fund operations, but the persistent negative retained earnings highlight ongoing profitability challenges.

Total debt remained relatively stable around $340M, but the D/E ratio swung dramatically due to the equity raise. The initial increase in leverage in 2025Q4 suggests the company may have drawn down on credit lines, but the subsequent equity issuance reduced leverage, indicating a deliberate deleveraging. This may imply that management is prioritizing balance sheet flexibility, possibly to support future growth or to mitigate refinancing risk, though the absolute debt level remains substantial relative to cash.

The rise in PPE from $48.7M in 2024Q1 to $89.8M in 2026Q2 indicates a shift towards a more asset-heavy model, possibly to support manufacturing capabilities. Goodwill remains a significant portion of total assets, at about 24%, but has been stable, reducing impairment risk. The increase in cash, though modest, provides a small buffer, but the overall asset mix still leans heavily on intangibles, which may be a concern if growth slows.

The equity increase is almost entirely due to new capital raises, as retained losses continue to widen. This suggests that the company is not yet self-sustaining and is dependent on investor funding. The lack of share repurchases (except a small buyback in 2025Q2) and no dividends indicate that all capital is being reinvested, but the dilution from SBC, which averaged over $10M per quarter, further erodes existing shareholder value. Investors should monitor whether the company can achieve profitability to justify the equity dilution.

While the current ratio appears healthy, the absolute cash balance is low, and the company's operating cash flow has been volatile. The high current ratio is likely driven by receivables and other current assets, not cash. Given the debt load, the company may face liquidity constraints if cash flows do not improve. The recent equity raise provides some cushion, but the reliance on external funding for liquidity is a concern.